The American Cancer Society is partnering with the Atlanta-based Global Center for Medical Innovation (GCMI) to more rapidly bring groundbreaking research from the lab to the clinic. ACS and GCMI plan to jointly raise $5 million to sustain the program.
While ACS conducts research and funds research through grants to hundreds of scientists and health professionals nationwide, bridging the gap between early research and actual treatment can often be very challenging.
In its role, GCMI will bring together members of the medical device community, including universities, research centers, hospitals, clinicians, and investors, to accelerate commercialization of innovative medical technologies that come out of ACS-funded research, while reducing the time and cost of bringing new ideas to market.
“Fostering efficient, rapid innovation from the bench to the bedside in cancer care is a high priority for the ACS,” says Bill Chambers, PhD., our senior vice president, Extramural Research. “This new partnership will allow GCMI and the ACS to identify, develop, and promote technology innovation from among projects within the ACS portfolio of funded research.”
Bill noted: “We will initially focus on medical device research which we have previously funded and which is poised for further development in partnership with GCMI. For instance, things like imaging tools for real time monitoring of tumor growth or response to treatment.”
The ACS has funded more than 24,000 investigators through its Extramural Research program, and this provides a wealth of opportunities which may benefit patients as a result of this partnership.
Three to five projects will be identified and launched each year with the goal of initiating one project each quarter.
Project duration will be assessed during the kick-off phase, which includes the identification of resource needs, e.g., external experts, time and materials, and the creation of a timeline for the innovators to reach key developmental milestones.
More about the Global Center for Medical Innovation
GCMI is the Southeast’s first and only comprehensive medical device innovation center dedicated to accelerating development, building businesses, and improving health. It opened in April 2012, and to date has worked with more than 50 different startups, clinician innovators, university tech transfer offices, and academic researchers to design, engineer, prototype, and facilitate commercialization of a broad range of innovative medical devices. It is an independent, 501(c)(3) non-profit organization.